Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis have won ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Nearly five months since revealing her multiple sclerosis diagnosis, Selma Blair is sharing her story. Just days after making her first public appearance since the announcement at the Oscars 2019 ...

After an inspiring appearance at the Vanity Fair Oscars after-party, Selma Blair is using the spotlight to bring attention to life with multiple sclerosis. RELATED: Selma Blair dons stunning, ...

Embed <iframe src="https://www.npr.org/player/embed/898856/898857" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player"> An ...

The Marburg variant of multiple sclerosis is extremely rare but also the most severe. Life expectancy has been weeks or months, but advances in treatment have led to an improved outlook. Multiple ...